Raptor Pharmaceutical Provides Topline Results From Phase 2b CyNCh Study Evaluating RP103 in Pediatric Nonalcoholic Steatohepatitis
September 14, 2015 07:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced topline results from the Phase 2b CyNCh study, which did not meet its primary endpoint of...
Raptor Pharmaceutical to Hold Second Quarter 2015 Financial Results Conference Call and Webcast on Thursday, August 6, 2015, at 4:30 p.m. EDT
July 30, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release second quarter 2015 financial results on Thursday, August 6,...
Raptor Pharmaceutical to Participate in Upcoming Investor Conferences
May 28, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Julie Anne Smith, President and Chief Executive Officer, will present at the following...
Raptor Pharmaceutical to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference
May 06, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference:
Julie Anne Smith, President and Chief...
Raptor Pharmaceutical to Hold First Quarter 2015 Financial Results Conference Call and Webcast on Thursday, May 7, 2015 at 4:30 p.m. EDT
April 30, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release first quarter 2015 financial results on Thursday, May 7, 2015...
Raptor Pharmaceutical to Host Investor Day on April 30, 2015
April 23, 2015 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) will host an Investor Day on Thursday, April 30, 2015, from 8:30 a.m. to 12:00 p.m. EDT (5:30 a.m. to 9:00...
Raptor Pharmaceutical to Attend Upcoming Conference
April 08, 2015 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Krishna Polu, M.D., Chief Medical Officer, will be a speaker at the following...
Raptor Pharmaceutical Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
April 08, 2015 12:13 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...
Raptor Pharmaceutical Announces Pricing of Public Offering of Common Stock
April 02, 2015 07:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 2, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...
Raptor Pharmaceutical to Attend Upcoming Investor Conferences
February 18, 2015 08:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor...